512217
PRISMMEDI
Start SIP
Invest Now
Start SIP in PRISMMEDI
Performance
- Low
- ₹19
- High
- ₹20
- 52 Week Low
- ₹12
- 52 Week High
- ₹26
- Open Price₹20
- Previous Close₹20
- Volume3,545
Investment Returns
- Over 1 Month + 4.01%
- Over 3 Month + 1.29%
- Over 6 Month + 36.62%
- Over 1 Year -19.43%
Smart Investing Starts Here Start SIP with Prism Medico and Pharmacy for Steady Growth!
Prism Medico and Pharmacy Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.8
- PEG Ratio
- 0
- Market Cap Cr
- 12
- P/B Ratio
- 0.8
- Average True Range
- 1.19
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.02
- RSI
- 55.68
- MFI
- 55.39
Prism Medico and Pharmacy Financials
Prism Medico and Pharmacy Technicals
EMA & SMA
Current Price
₹19.70
-0.08
(-0.4%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹18.95
- 50 Day
- ₹18.87
- 100 Day
- ₹18.41
- 200 Day
- ₹18.39
Resistance and Support
19.58
- R3 20.62
- R2 20.23
- R1 19.97
- S1 19.32
- S2 18.93
- S3 18.67
Prism Medico and Pharmacy Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix day, date, time and Notice for holding the 23rd AGM. 2. Director's Report along with all necessary annexures thereof. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Prism Medico and Pharmacy F&O
About Prism Medico and Pharmacy
- NSE Symbol
- PRISMMEDI
- BSE Symbol
- 512217
- ISIN
- INE730E01016
Similar Stocks to Prism Medico and Pharmacy
Prism Medico and Pharmacy FAQs
Prism Medico and Pharmacy share price is ₹19 As on 27 December, 2025 | 02:45
The Market Cap of Prism Medico and Pharmacy is ₹11.9 Cr As on 27 December, 2025 | 02:45
The P/E ratio of Prism Medico and Pharmacy is 19.8 As on 27 December, 2025 | 02:45
The PB ratio of Prism Medico and Pharmacy is 0.8 As on 27 December, 2025 | 02:45
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.